Ismail Hina, Yaseen Raja Taha, Danish Muhammad, Tasneem Abbas Ali, Hanif Farina, Hanif Farrah, Jariko Arshad, Laeeq Syed Mudassir, Majid Zain, Luck Nasir Hasan
Department of Hepatogastroenterology, Sindh Institute of Urology and Transplantation, Karachi, Sindh, Pakistan.
Euroasian J Hepatogastroenterol. 2022 Jan-Jun;12(1):19-23. doi: 10.5005/jp-journals-10018-1373.
Post-endoscopic retrograde cholangiopancreatography (ERCP) cholangitis (PEC) is associated with increased morbidity and mortality in patients ERCP. The aim of the present study was to analyze the predictors of PEC and to formulate a predictive model for early diagnosis and management.
It was a cross-sectional study that was carried out at the Sindh Institute of Urology and Transplantation from September 2019 to June 2021. All patients aged between 18 and 75 years and undergoing ERCP due to obstructive jaundice were included. Patients with altered biliary anatomy, history of hepatobiliary surgery, and concurrent sepsis were excluded. Endoscopic retrograde cholangiopancreatography intervention was performed by an expert gastroenterologist. Laboratory parameters (total leukocyte count, total bilirubin, alanine transaminase) and patient temperature were checked on admission, at 12 hours, 24 hours, and 36 hours after ERCP to document PEC.
A total of 349 patients were included in the study. Among them, 176 (50.4%) patients were males. Common bile duct (CBD) stricture was the most common indication of ERCP seen in 148 (42.4%) patients followed by CBD stone and cholangiocarcinoma in 108 (30.9%) and 48 (13.8%) patients, respectively. The most common presenting complaint was jaundice noted in 300 (86%) patients followed by right hypochondrial pain in 280 (80.2%) and weight loss in 194 (55.6%) patients, respectively. Post-ERCP cholangitis developed in 251 (71.9%) patients. On univariate analysis, age >50 years, female gender, right hypochondrial pain, fever, bilirubin >5 mg/dL on admission, CBD stricture on ERCP, TLC of >10,000 cells/L at 12 hours, 24 hours, and 36 hours post-ERCP and rise in ALT >50 IU 24 and 48 hours post-ERCP were significantly associated with PEC. While on multivariate analysis, female gender, bilirubin >5 mg/dL on admission, CBD stricture on ERCP, post-ERCP fever, and rise in TLC of >10000 cells/L at 24 hours post-ERCP were independently associated with PEC. HinCh score was formulated and was found to be significantly associated with the presence of cholangitis. Area under the receiver operating characteristics (AUROC) of HinCh score was 0.74 and at cutoff of ≥4, the sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of HinCh were 81.67%, 59.18%, 83.67%, and 55.71%, respectively with a diagnostic accuracy of 75.36%.
The performance of HinCh score in predicting PEC was accurate in 86% of the patients. However, further studies are needed to validate the score.
Ismail H, Yaseen RT, Danish M, . Role of "HinCh Score" as a Non-invasive Predictor of Post-endoscopic Retrograde Cholangiopancreatography Cholangitis. Euroasian J Hepato-Gastroenterol 2022;12(1):19-23.
内镜逆行胰胆管造影术(ERCP)后胆管炎(PEC)与接受ERCP患者的发病率和死亡率增加相关。本研究的目的是分析PEC的预测因素,并建立一个用于早期诊断和管理的预测模型。
这是一项横断面研究,于2019年9月至2021年6月在信德泌尿与移植研究所进行。纳入所有年龄在18至75岁之间、因梗阻性黄疸接受ERCP的患者。排除胆管解剖结构改变、肝胆手术史和并发脓毒症的患者。由一位专家胃肠病学家进行内镜逆行胰胆管造影干预。在入院时、ERCP后12小时、24小时和36小时检查实验室参数(白细胞总数、总胆红素、丙氨酸转氨酶)和患者体温,以记录PEC。
本研究共纳入349例患者。其中,176例(50.4%)为男性。胆总管(CBD)狭窄是ERCP最常见的适应证,148例(42.4%)患者出现该情况,其次是CBD结石和胆管癌,分别有108例(30.9%)和48例(13.8%)患者。最常见的主诉是黄疸,300例(86%)患者出现,其次是右季肋部疼痛,280例(80.2%)患者出现,体重减轻194例(55.6%)患者出现。251例(71.9%)患者发生了ERCP后胆管炎。单因素分析显示,年龄>50岁、女性、右季肋部疼痛、发热、入院时胆红素>5mg/dL、ERCP时CBD狭窄、ERCP后12小时、24小时和36小时白细胞总数>10,000个/L以及ERCP后24小时和48小时ALT升高>50IU与PEC显著相关。多因素分析显示,女性、入院时胆红素>5mg/dL、ERCP时CBD狭窄、ERCP后发热以及ERCP后24小时白细胞总数升高>10000个/L与PEC独立相关。制定了HinCh评分,发现其与胆管炎的存在显著相关。HinCh评分的受试者工作特征曲线下面积(AUROC)为0.74,在临界值≥4时,HinCh的敏感性、特异性、阳性预测值(PPV)和阴性预测值(NPV)分别为81.67%、59.18%、83.67%和55.71%,诊断准确率为75.36%。
HinCh评分在预测PEC方面对86%的患者准确。然而,需要进一步研究来验证该评分。
伊斯梅尔H,亚辛RT,丹麦M,等。“HinCh评分”作为内镜逆行胰胆管造影术后胆管炎的非侵入性预测指标的作用。欧亚肝脏胃肠病学杂志2022;12(1):19 - 23。